DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Novolin R (Insulin Human) - Anti-Insulin Antibody Positive - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Anti-Insulin Antibody Positive (9)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Novolin R (Insulin Human) where reactions include anti-insulin antibody positive. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Novolin R side effects in 51 year old male

Reported by a physician from Japan on 2012-07-05

Patient: 51 year old male

Reactions: Anti-Insulin Antibody Positive, Hypoglycaemia

Drug(s) suspected as cause:
Novolin R
    Dosage: 80 u, qd
    Indication: Type 2 Diabetes Mellitus
    Start date: 2003-11-01

Novolin R
    Dosage: unk
    Indication: Type 2 Diabetes Mellitus
    Start date: 2002-12-01



Possible Novolin R side effects in 51 year old male

Reported by a physician from Japan on 2012-07-02

Patient: 51 year old male

Reactions: Anti-Insulin Antibody Positive, Hypoglycaemia

Drug(s) suspected as cause:
Novolin R
    Dosage: unk
    Indication: Type 2 Diabetes Mellitus
    Start date: 2002-12-01

Novolin R
    Dosage: 80 u, qd
    Indication: Type 2 Diabetes Mellitus
    Start date: 2003-11-01



Possible Novolin R side effects in 61 year old male

Reported by a physician from Japan on 2012-06-18

Patient: 61 year old male, weighing 82.0 kg (180.4 pounds)

Reactions: Anti-Insulin Antibody Positive, Hypoglycaemia, Diabetes Mellitus Inadequate Control

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Novolin R
    Dosage: 34 u, qd (18-12-4ut)
    Indication: Type 2 Diabetes Mellitus

Novorapid CHU Flexpen
    Dosage: 90 u, qd (28-30-32ut)
    Indication: Type 2 Diabetes Mellitus

Novorapid CHU Flexpen
    Dosage: 50 u, qd

Other drugs received by patient: Diovan; Amlodipine; Actos; Rasilez; Pravastatin Sodium; Lantus; Voglibose



Possible Novolin R side effects in 61 year old male

Reported by a physician from Japan on 2012-05-17

Patient: 61 year old male, weighing 82.0 kg (180.4 pounds)

Reactions: Anti-Insulin Antibody Positive, Hypoglycaemia, Diabetes Mellitus Inadequate Control

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Novorapid CHU Flexpen
    Dosage: 50 u, qd

Novorapid CHU Flexpen
    Dosage: 90 u, qd (28-30-32ut)
    Indication: Type 2 Diabetes Mellitus

Novolin R
    Dosage: 34 u, qd (18-12-4ut)
    Indication: Type 2 Diabetes Mellitus

Other drugs received by patient: Amlodipine Besylate; Lantus; Pravastatin Sodium



Possible Novolin R side effects in 60 year old male

Reported by a physician from Japan on 2012-05-16

Patient: 60 year old male, weighing 48.0 kg (105.6 pounds)

Reactions: Anti-Insulin Antibody Positive, Diabetes Mellitus Inadequate Control

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Novolin R

Other drugs received by patient: Nichiaspirin; Reticolan; Corinael; Amlodipine Besylate; Metformin HCL



Possible Novolin R side effects in 60 year old male

Reported by a physician from Japan on 2012-05-08

Patient: 60 year old male, weighing 48.0 kg (105.6 pounds)

Reactions: Anti-Insulin Antibody Positive, Diabetes Mellitus Inadequate Control

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Novolin R

Other drugs received by patient: Corinael; Nichiaspirin; Amlodipine; Metformin HCL; Reticolan



Possible Novolin R side effects in 73 year old male

Reported by a physician from Japan on 2012-03-30

Patient: 73 year old male, weighing 52.0 kg (114.4 pounds)

Reactions: Anti-Insulin Antibody Positive, Hyperglycaemia, Hypoglycaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Novolin N
    Dosage: unk
    Indication: Type 2 Diabetes Mellitus
    Start date: 2011-05-06

Novorapid CHU Flexpen
    Dosage: unk
    Indication: Type 2 Diabetes Mellitus
    Start date: 2010-02-12
    End date: 2011-05-06

Novolin R
    Dosage: unk
    Indication: Type 2 Diabetes Mellitus
    Start date: 2011-05-06

Other drugs received by patient: Humalog; Lantus; Humulin N; Urso / 00465701 /; Candesartan Cilexetil; Adalat CC



Possible Novolin R side effects in 84 year old male

Reported by a physician from Japan on 2012-02-16

Patient: 84 year old male, weighing 42.0 kg (92.4 pounds)

Reactions: Anti-Insulin Antibody Positive, Hypoglycaemia, Hyperglycaemia, Anti-Insulin Antibody Increased, Diabetes Mellitus Inadequate Control

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Novolin R
    Dosage: 120 u, qd

Humalog
    Dosage: 20 ut, qd
    Indication: Type 2 Diabetes Mellitus
    Start date: 2010-03-17
    End date: 2011-02-21

Apidra
    Dosage: 12 ut, qd
    Indication: Type 2 Diabetes Mellitus
    Start date: 2011-02-21

Novolin R
    Dosage: 10 ut, qd
    Indication: Type 2 Diabetes Mellitus
    Start date: 2010-03-25
    End date: 2011-02-21

Novorapid 30 MIX CHU Flexpen
    Dosage: 8 u, qd
    Indication: Type 2 Diabetes Mellitus
    Start date: 2010-02-18
    End date: 2011-02-21

Other drugs received by patient: Pletal; Nicoranta; Aspirin; Sitagliptin Phosphate; Diart; Lipitor; Amaryl; Allopurinol; Millis; Magmitt; Mucosta



Possible Novolin R side effects in 84 year old male

Reported by a physician from Japan on 2012-02-06

Patient: 84 year old male, weighing 42.0 kg (92.4 pounds)

Reactions: Anti-Insulin Antibody Positive, Hypoglycaemia, Hyperglycaemia, Anti-Insulin Antibody Increased, Diabetes Mellitus Inadequate Control

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Apidra
    Dosage: 12 ut, qd
    Indication: Type 2 Diabetes Mellitus
    Start date: 2011-02-21

Novolin R
    Dosage: 120 u, qd

Novorapid 30 MIX CHU Flexpen
    Dosage: 8 u, qd
    Indication: Type 2 Diabetes Mellitus
    Start date: 2010-02-18
    End date: 2011-02-21

Novolin R
    Dosage: 10 ut, qd
    Indication: Type 2 Diabetes Mellitus
    Start date: 2010-03-25
    End date: 2011-02-21

Humalog
    Dosage: 20 ut, qd
    Indication: Type 2 Diabetes Mellitus
    Start date: 2010-03-17
    End date: 2011-02-21

Other drugs received by patient: Aspirin; Pletal; Amaryl; Nicoranta; Mucosta; Diart; Millis; Magmitt; Sitagliptin Phosphate; Allopurinol; Lipitor

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017